The Sepsis Diagnostics Market is expanding as healthcare systems place greater emphasis on rapid identification and management of sepsis. Diagnostic technologies such as molecular diagnostics, microbiology, immunoassays, flow cytometry, and biomarker testing are helping healthcare professionals obtain clinically useful information more efficiently. According to the latest Market Research Future assessment, the market was valued at USD 0.85 billion in 2025 and is projected to reach USD 1.69 billion by 2035, growing at a CAGR of 7.1% during 2026–2035.

The growing burden of sepsis, hospital-acquired infections, antimicrobial resistance, and increasing demand for early diagnosis are supporting industry expansion. Molecular diagnostics accounted for the largest technology share in 2025, while immunoassays are projected to grow strongly. Assays and reagents represent a major product category because of recurring laboratory demand. Market Growth is also being encouraged by point-of-care testing, automated laboratory systems, and AI-supported clinical decision tools.

FAQ: What is sepsis diagnostics?
Sepsis diagnostics includes laboratory and clinical testing methods used to identify infection, pathogens, and biomarkers associated with sepsis.

FAQ: What drives the market?
Rising sepsis incidence, demand for rapid testing, technological advances, and increasing hospital investment in diagnostic infrastructure are major drivers.